UPDATE 3-Evolus investors frown as FDA declines to approve Botox rival By: Reuters: Company News May 16, 2018 at 14:27 PM EDT * Deficiencies not related to clinical or non-clinical matters Read More >> Related Stocks: Allergan Plc Evolus Inc Mylan Revance Therapeutics